Li Mao Selected Research

Adenosine Triphosphate (ATP)

1/2020	Hippocampal CD39/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP.
2/2016	A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Mao Research Topics

Disease

81	Neoplasms (Cancer) 04/2024 - 05/2002
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 05/2002
20	Lung Neoplasms (Lung Cancer) 06/2023 - 09/2002
20	Carcinogenesis 01/2021 - 01/2002
14	Squamous Cell Carcinoma of Head and Neck 05/2015 - 01/2002
12	Infections 11/2022 - 01/2018
12	Mouth Neoplasms (Oral Cancer) 01/2018 - 12/2003
10	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2002
10	Inflammation (Inflammations) 08/2023 - 04/2006
6	Breast Neoplasms (Breast Cancer) 11/2023 - 02/2006
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2005
6	Head and Neck Neoplasms (Head and Neck Cancer) 11/2015 - 01/2002
5	Virus Diseases (Viral Diseases) 04/2023 - 10/2018
5	Adenocarcinoma of Lung 01/2020 - 09/2002
4	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2014
4	Insulin Resistance 01/2022 - 09/2017
4	Vitamin D Deficiency 01/2022 - 01/2014
4	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2020
4	Adenocarcinoma 01/2021 - 04/2006
4	Disease Progression 01/2021 - 04/2010
4	Carcinoma (Carcinomatosis) 04/2010 - 11/2002
3	Reperfusion Injury 01/2023 - 11/2017
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 11/2017
3	Paramyxoviridae Infections (Parainfluenza) 11/2022 - 09/2020
3	Fatigue 05/2020 - 08/2010
3	Osteonecrosis (Kienbock's Disease) 01/2017 - 03/2015
3	Oral Leukoplakia 01/2013 - 03/2004
2	Radiation Pneumonitis 11/2023 - 07/2009
2	Osteoporosis 02/2023 - 01/2017
2	Weight Loss (Weight Reduction) 10/2022 - 07/2021
2	Fibrosis (Cirrhosis) 01/2022 - 06/2021
2	Glucose Intolerance 01/2022 - 11/2021
2	Body Weight (Weight, Body) 07/2021 - 06/2006
2	Type 2 Diabetes Mellitus (MODY) 07/2021 - 01/2019
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2021 - 01/2020
2	Proteinuria 05/2020 - 01/2014
2	Exanthema (Rash) 01/2020 - 02/2016
2	Hypertension (High Blood Pressure) 01/2020 - 04/2014

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2002
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2002
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2003
9	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2007
9	Messenger RNA (mRNA)IBA 05/2017 - 09/2002
8	RNA (Ribonucleic Acid)IBA 01/2024 - 03/2017
8	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2017
8	ensartinibIBA 11/2021 - 01/2020
6	Insulin (Novolin)FDA Link 08/2023 - 07/2017
5	Tyrosine Kinase InhibitorsIBA 11/2021 - 06/2009
5	Indicators and Reagents (Reagents)IBA 01/2013 - 11/2002
4	Long Noncoding RNAIBA 01/2022 - 10/2015
4	Vitamin D FDA LinkGeneric 01/2022 - 01/2014
4	CrizotinibIBA 11/2021 - 01/2018
4	Anaplastic Lymphoma KinaseIBA 11/2021 - 01/2020
4	Interleukin-6 (Interleukin 6)IBA 05/2017 - 08/2010
4	ZincIBA 12/2016 - 01/2012
4	ProteomeIBA 02/2016 - 09/2013
3	Circular RNAIBA 04/2024 - 01/2020
3	CytokinesIBA 01/2024 - 08/2010
3	AntibodiesIBA 01/2024 - 05/2009
3	Monoclonal AntibodiesIBA 01/2024 - 05/2009
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2022 - 01/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2021
3	CopperIBA 01/2021 - 12/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2011
3	Piwi-Interacting RNAIBA 03/2017 - 08/2013
3	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017 - 11/2011
3	LigandsIBA 04/2015 - 12/2004
3	SmokeIBA 01/2013 - 07/2008
3	Phosphotransferases (Kinase)IBA 11/2012 - 06/2009
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2012 - 10/2003
3	Small Interfering RNA (siRNA)IBA 06/2012 - 01/2006
3	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2010 - 10/2003
3	hepatoma-derived growth factorIBA 05/2009 - 08/2004
3	Death-Associated Protein KinasesIBA 12/2004 - 01/2002
2	Peptides (Polypeptides)IBA 04/2024 - 05/2011
2	indolepropanol phosphate (IPP)IBA 08/2023 - 01/2022
2	InflammasomesIBA 01/2023 - 01/2020
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2018
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 01/2014
2	EnzymesIBA 01/2022 - 10/2003
2	Competitive Endogenous RNAIBA 01/2022 - 01/2020
2	oxymatrineIBA 07/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 07/2021 - 01/2019
2	InterferonsIBA 03/2021 - 02/2020
2	vorolanibIBA 02/2021 - 05/2020
2	Penicillamine (Cuprimine)FDA Link 01/2021 - 01/2020
2	icotinibIBA 01/2021 - 01/2020
2	PolyphenolsIBA 11/2020 - 05/2017
2	Viral ProteinsIBA 09/2020 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 02/2016
2	CarbonIBA 11/2019 - 12/2018

Therapy/Procedure

20	Therapeutics 01/2024 - 02/2006
12	Drug Therapy (Chemotherapy) 04/2023 - 04/2004
9	Chemoprevention 01/2018 - 01/2002
6	Radiotherapy 01/2011 - 11/2002
5	Immunotherapy 01/2024 - 01/2011
2	Adjuvant Radiotherapy 11/2023 - 08/2008
2	Lasers (Laser) 09/2020 - 11/2003